Enterprise AI Analysis

Computational Screening of AI-Generated Antihypertensive Virtual Leads for Polypharmacological Anticancer Potential

This study computationally investigates the polypharmacological anticancer potential of AI-generated antihypertensive virtual lead compounds by re-evaluating their interaction profiles across multiple cancer-associated protein targets. By integrating drug-likeness and pharmacokinetic screening with molecular docking, binding free energy estimation, pharmacophore modeling, and molecular dynamics simulations, a systematic in silico framework was established. The findings indicate that several hypothetically evaluated compounds exhibit favorable physicochemical properties, acceptable predicted pharmacokinetic and safety profiles, and consistent predicted binding affinities across multiple cancer-relevant targets, suggesting a robust hypothesis for their utility in oncology. Binding free energy analyses and dynamic simulations provide support for the stability and persistence of key ligand-target interactions, increasing the plausibility of polypharmacological engagement rather than isolated target-specific effects. These results underscore the utility of computational re-profiling strategies in expanding the hypothesized therapeutic relevance of AI-designed chemical libraries and advancing polypharmacological drug discovery paradigms. The study prioritizes molecules for further experimental validation in cancer cell lines.